Diagnostic in vitro method for assessing Von Willebrand Disease and bleeding risk associated with Von Willebrand Disease and acquired or congenital disorders of platelet function

摘要

The invention relates to a diagnostic in-vitro method for assessing for diagnosing von Willebrand Disease and bleeding risk associated with von Willebrand Disease and platelet function disorders. The method is suitable for use as a screening method based on whole blood and has the additional benefit of being suitable as a point of care diagnostic method. The method involves the incubation of a sample from a human individual or an animal comprising a body fluid which contains platelets and haemostasis factors with an activator of platelet aggregation and the measurement of the viscoelastic change after inducing coagulation, preferably by means of thromboelastography (TEG).